Literature DB >> 25113304

The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology.

Mike A Laffan1, Will Lester, James S O'Donnell, Andrew Will, Robert Campbell Tait, Anne Goodeve, Carolyn M Millar, David M Keeling.   

Abstract

Entities:  

Keywords:  United Kingdom Haemophilia Centre Doctors Organization; diagnosis; guideline; management; von Willebrand

Mesh：

Year:  2014        PMID： 25113304      PMCID： PMC4283483          DOI： 10.1111/bjh.13064

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  87 in total

1.  Pregnancy in type 2B VWD: a case series.

Authors:  A Ranger; R A Manning; H Lyall; M A Laffan; C M Millar
Journal:  Haemophilia       Date:  2011-11-14       Impact factor: 4.287

2.  A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).

Authors:  A Tosetto; F Rodeghiero; G Castaman; A Goodeve; A B Federici; J Batlle; D Meyer; E Fressinaud; C Mazurier; J Goudemand; J Eikenboom; R Schneppenheim; U Budde; J Ingerslev; Z Vorlova; D Habart; L Holmberg; S Lethagen; J Pasi; F Hill; I Peake
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

3.  The von Willebrand disease prophylaxis network: exploring a treatment concept.

Authors:  E Berntorp; T Abshire
Journal:  J Thromb Haemost       Date:  2006-11       Impact factor: 5.824

4.  Use of recombinant factor VIIa (NovoSeven) in the treatment of two patients with type III von Willebrand's disease and an inhibitor against von Willebrand factor.

Authors:  N Ciavarella; M Schiavoni; E Valenzano; F Mangini; F Inchingolo
Journal:  Haemostasis       Date:  1996

Review 5.  A systematic review: The use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy.

Authors:  D E Trigg; I Stergiotou; P Peitsidis; R A Kadir
Journal:  Haemophilia       Date:  2011-05-30       Impact factor: 4.287

Review 6.  The evolution and value of bleeding assessment tools.

Authors:  Natalia Rydz; Paula D James
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

Review 7.  Bleeders, bleeding rates, and bleeding score.

Authors:  A Tosetto; G Castaman; F Rodeghiero
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

Review 8.  How I treat patients with von Willebrand disease.

Authors:  P M Mannucci
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

9.  Differential sensitivity of von Willebrand factor (VWF) 'activity' assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen-binding and mAb-based assays.

Authors:  E J Favaloro; R Bonar; K Chapman; M Meiring; D Funk Adcock
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

10.  Efficacy and safety of a new generation von Willebrand factor/factor VIII concentrate (Wilate®) in the management of perioperative haemostasis in von Willebrand disease patients undergoing surgery.

Authors:  J Windyga; M von Depka-Prondzinski
Journal:  Thromb Haemost       Date:  2011-03-24       Impact factor: 5.249
View more
  64 in total

1.  An international survey to inform priorities for new guidelines on von Willebrand disease.

Authors:  Mohamad A Kalot; Mohammed Al-Khatib; Nathan T Connell; Veronica Flood; Romina Brignardello-Petersen; Paula James; Reem A Mustafa
Journal:  Haemophilia       Date:  2019-11-26       Impact factor: 4.287

2.  Effectiveness and safety of hFVIII/VWF concentrate (Voncento®) in patients with inherited von Willebrand disease requiring surgical procedures: the OPALE multicentre observational study.

Authors:  Lucia Rugeri; Roseline d'Oiron; Annie Harroche; Valérie Proulle; Guillaume Mourey; Emmanuelle De Raucourt; Dominique Desprez; Nathalie Itzhar Baikian; Brigitte Pan Petesch; Annie Borel-Derlon; Sophie Combe; Birgit Frotscher; Abel Hassoun; Hasan Catovic; Diane Bracquart; Marc Trossaërt
Journal:  Blood Transfus       Date:  2020-11-27       Impact factor: 3.443

Review 3.  Diagnostic approach to von Willebrand disease.

Authors:  Christopher Ng; David G Motto; Jorge Di Paola
Journal:  Blood       Date:  2015-02-23       Impact factor: 22.113

4.  The role of genetics in the pathogenesis and diagnosis of type 1 Von Willebrand disease.

Authors:  Veronica H Flood; Jessica Garcia; Sandra L Haberichter
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.284

Review 5.  Haemostatic disorders in pregnancy.

Authors:  R Agarwala; C M Millar; J P Campbell
Journal:  BJA Educ       Date:  2020-03-18

6.  Von Willebrand disease in the United States: perspective from the Zimmerman program.

Authors:  Veronica H Flood; Thomas C Abshire; Pamela A Christopherson; Kenneth D Friedman; Joan Cox Gill; Robert R Montgomery; Sandra L Haberichter
Journal:  Ann Blood       Date:  2018-01-26

7.  Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels.

Authors:  Michelle Lavin; Sonia Aguila; Sonja Schneppenheim; Niall Dalton; Kenneth L Jones; Jamie M O'Sullivan; Niamh M O'Connell; Kevin Ryan; Barry White; Mary Byrne; Marie Rafferty; Mairead M Doyle; Margaret Nolan; Roger J S Preston; Ulrich Budde; Paula James; Jorge Di Paola; James S O'Donnell
Journal:  Blood       Date:  2017-09-15       Impact factor: 22.113

8.  3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology.

Authors:  Danielle Menosi Gualandro; Pai Ching Yu; Bruno Caramelli; André Coelho Marques; Daniela Calderaro; Luciana Savoy Fornari; Claudio Pinho; Alina Coutinho Rodrigues Feitosa; Carisi Anne Polanczyk; Carlos Eduardo Rochitte; Carlos Jardim; Carolina L Z Vieira; Debora Y M Nakamura; Denise Iezzi; Dirk Schreen; Eduardo Leal Adam; Elbio Antonio D'Amico; Emerson Q de Lima; Emmanuel de Almeida Burdmann; Enrique Indalecio Pachón Mateo; Fabiana Goulart Marcondes Braga; Fabio S Machado; Flavio J de Paula; Gabriel Assis Lopes do Carmo; Gilson Soares Feitosa-Filho; Gustavo Faibischew Prado; Heno Ferreira Lopes; João R C Fernandes; José J G de Lima; Luciana Sacilotto; Luciano Ferreira Drager; Luciano Janussi Vacanti; Luis Eduardo Paim Rohde; Luis F L Prada; Luis Henrique Wolff Gowdak; Marcelo Luiz Campos Vieira; Maristela Camargo Monachini; Milena Frota Macatrão-Costa; Milena Ribeiro Paixão; Mucio Tavares de Oliveira; Patricia Cury; Paula R Villaça; Pedro Silvio Farsky; Rinaldo F Siciliano; Roberto Henrique Heinisch; Rogerio Souza; Sandra F M Gualandro; Tarso Augusto Duenhas Accorsi; Wilson Mathias
Journal:  Arq Bras Cardiol       Date:  2017 Jan-Feb       Impact factor: 2.000

Review 9.  Current controversies in the diagnosis and management of von Willebrand disease.

Authors:  Anne T Neff
Journal:  Ther Adv Hematol       Date:  2015-08

Review 10.  Effect of Desmopressin on Platelet Dysfunction During Antiplatelet Therapy: A Systematic Review.

Authors:  Lise Kjær Andersen; Anne-Mette Hvas; Christine Lodberg Hvas
Journal:  Neurocrit Care       Date:  2020-08-04       Impact factor: 3.210
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.